Literature DB >> 9037199

Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product.

M Tanaka1, H Sato, T Takino, K Iwata, M Inoue, M Seiki.   

Abstract

We have isolated a new MT-MMP related gene of 3.3 kb from a mouse lung cDNA library using a human MT1-MMP cDNA as a probe. The deduced protein sequence shows 87% homology to human MT2-MMP and 52, 50 and 29% to MT1-MMP, MT3-MMP and MT4-MMP, respectively. Thus the gene is thought to be a mouse homologue of human MT2-MMP. A monoclonal antibody raised against a synthetic peptide recognized mouse MT2-MMP as a 70 kDa protein. Like MT1- and MT3-MMPs, mouse MT2-MMP caused activation of progelatinase A upon co-transfection into COS-1 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037199     DOI: 10.1016/s0014-5793(96)01537-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).

Authors:  Joji Iida; Krista L Wilhelmson; Janet Ng; Peter Lee; Charlotte Morrison; Eric Tam; Christopher M Overall; James B McCarthy
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

2.  Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and prognosis.

Authors:  Shi-Kai Zhu; Yu Zhou; Chao Cheng; Shan Zhong; Han-Qing Wu; Bo Wang; Ping Fan; Jiong-Xin Xiong; Hong-Ji Yang; He-Shui Wu
Journal:  Mol Clin Oncol       Date:  2014-07-09

3.  Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.

Authors:  N Théret; O Musso; A L'Helgoualc'h; J P Campion; B Clément
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  LPP inhibits collective cell migration during lung cancer dissemination.

Authors:  S Kuriyama; M Yoshida; S Yano; N Aiba; T Kohno; Y Minamiya; A Goto; M Tanaka
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

5.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Authors:  M Nakada; H Nakamura; E Ikeda; N Fujimoto; J Yamashita; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 6.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

7.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

8.  Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Authors:  S Ishigaki; M Toi; T Ueno; H Matsumoto; M Muta; M Koike; M Seiki
Journal:  Jpn J Cancer Res       Date:  1999-05

9.  Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line.

Authors:  T Harayama; E Ohuchi; T Aoki; H Sato; M Seiki; Y Okada
Journal:  Jpn J Cancer Res       Date:  1999-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.